Thomas Graney

The sales of Thomas Graney are small: 5 trades worth EUR 311,046, with a median of EUR 22,770. Two of them, at Vertex Pharmaceuticals INC / MA, where the listed title is Chief Financial Officer, dominate: EUR 179,594 on October 1, 2018 and EUR 96,999 on January 2, 2018. The third, EUR 22,770, dates from February 22, 2017 at Ironwood Pharmaceuticals Inc, also as Chief Financial Officer. No purchase is recorded.

The 10 filings, published from February 26, 2016 to May 10, 2024, are split between Ironwood Pharmaceuticals Inc (5), Vertex Pharmaceuticals INC / MA (4) and Notable Labs, Ltd. (1, Director). They include 5 grants. The calendar is concentrated: 2 filings in 2016, 4 in 2017, 3 in 2018, then a single one in 2024. The publication delay is a median of 2 days. No filing falls in the last twelve months.

Graney's own market trades within 30 days of colleagues at Ironwood Pharmaceuticals Inc number 3, 3 and 3. Every one in the same direction. Names in order: Gina Consylman, Halley E. Gilbert and Lawrence S. Olanoff.